Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 56, Issue , 2015, Pages 254-263

  Doboszewska, Urszula ^a   Sowa Kućma, Magdalena ^a   Młyniec, Katarzyna ^b   Pochwat, Bartłomiej ^a   Hołuj, Malgorzata ^a   Ostachowicz, Beata ^c   Pilc, Andrzej ^a,b   Nowak, Gabriel ^a,b   Szewczyk, Bernadeta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Forced swim test; NMDA receptor; Social interaction test; Sucrose intake test; Zinc deficiency

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUN2A PROTEIN; GLUN2B PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; UNCLASSIFIED DRUG; DLGH4 PROTEIN, RAT; MEMBRANE PROTEIN; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A; NR2B NMDA RECEPTOR; SIGNAL PEPTIDE; SUCROSE; ZINC;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION TEST; SUCROSE PREFERENCE TEST; UPREGULATION; ZINC DEFICIENCY; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BRAIN; DEFICIENCY; FOOD PREFERENCE; HUMAN RELATION; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SWIMMING; TIME;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FOOD PREFERENCES; INTERPERSONAL RELATIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUCROSE; SWIMMING; TIME FACTORS; UP-REGULATION; ZINC;

EID: 84908191380     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.09.013     Document Type: Article

References (73)

1. Aan Het Rot M., Zarate C.A., Charney D.S., Mathew S.J. Ketamine for depression: where do we go from here?. Biol Psychiatry 2012, 72:537-547.
2. Berman R., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47:351-354.
3. Boulle F., Kenis G., Cazorla M., Hamon M., Steinbusch H.W., Lanfumey L., et al. TrkB inhibition as a therapeutic target for CNS-related disorders. Prog Neurobiol 2012, 98:197-206.
4. Brandoli C., Sanna A., De Bernardi M.A., Follesa P., Brooker G., Mocchetti I. Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. J Neurosci 1998, 18:7953-7961.
5. Calabrese F., Guidotti G., Molteni R., Racagni G., Mancini M., Riva M.A. Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment. PLoS One 2012, 7:e37916.
6. Cazorla M., Premont J., Mann A., Girard N., Kellendonk C., Rognan D. Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 2011, 121:1846-1857.
7. Chen N., Moshaver A., Raymond L.A. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol 1997, 51:1015-1023.
8. Chen X., Nelson C.D., Li X., Winters C.A., Azzam R., Sousa A.A., et al. PSD-95 is required to sustain the molecular organization of the postsynaptic density. J Neurosci 2011, 31:6329-6338.
9. Christine C.W., Choi D.W. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci 1990, 10:108-116.
10. Cieslik K., Klenk-Majewska B., Danilczuk Z., Wrobel A., Lupina T., Ossowska G. Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep 2007, 59:46-52.
11. Cope E.C., Morris D.R., Scrimgeour A.G., VanLandingham J.W., Levenson C.W. Zinc supplementation provides behavioral resiliency in a rat model of traumatic brain injury. Physiol Behav 2011, 104:942-947.
12. Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967, 113:1237-1264.
13. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001, 11:327-335.
14. Cunha M.P., Machado D.G., Bettio L.E., Capra J.C., Rodrigues A.L. Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1913-1920. 10.1016/j.pnpbp.2008.09.006.
15. Duman R.S., Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 2012, 35:47-56.
16. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
17. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med 1998, 4:1313-1317.
18. Feyissa A.M., Chandran A., Stockmeier C.A., Karolewicz B. Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:70-75.
19. Frederickson C.J., Suh S.W., Silva D., Frederickson C.J., Thompson R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 2000, 130:1471S-1483S.
20. Grimm S., Luborzewski A., Schubert F., Merkl A., Kronenberg G., Colla M., et al. Region-specific glutamate changes in patients with unipolar depression. J Psychiatr Res 2012, 46:1059-1065.
21. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010, 11:682-696.
22. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002, 5:405-414.
23. Jacka F.N., Maes M., Pasco J.A., Williams L.J., Berk M. Nutrient intakes and the common mental disorders in women. J Affect Disord 2012, 141:79-85.
24. Jacka F.N., Mykletun A., Berk M. Moving towards a population health approach to the primary prevention of common mental disorders. BMC Med 2012, 10. [10:149-7015-10-149].
25. Kang H.J., Voleti B., Hajszan T., Rajkowska G., Stockmeier C.A., Licznerski P., et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 2012, 18:1413-1417.
26. Köhr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res 2006, 326:439-446.
27. Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 1995, 269:1737-1740.
28. Kroczka B., Zieba A., Dudek D., Pilc A., Nowak G. Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 2000, 52:403-406.
29. Kroczka B., Branski P., Palucha A., Pilc A., Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 2001, 55:297-300. [DOI: S0361-9230(01)00473-7 [pii]].
30. Kupfer D.J., Frank E., Phillips M.L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012, 379:1045-1055.
31. Lai J., Moxey A., Nowak G., Vashum K., Bailey K., McEvoy M. The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J Affect Disord 2012, 136:e31-e39. 10.1016/j.jad.2011.06.022.
32. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
33. Luo J., Wang T., Liang S., Hu X., Li W., Jin F. Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats. Behav Brain Funct 2013, 9:46.
34. Maserejian N.N., Hall S.A., McKinlay J.B. Low dietary or supplemental zinc is associated with depression symptoms among women, but not men, in a population-based epidemiological survey. J Affect Disord 2012, 136:781-788.
35. Migaud M., Charlesworth P., Dempster M., Webster L.C., Watabe A.M., Makhinson M., et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 1998, 396:433-439.
36. Mlyniec K., Nowak G. Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacol Rep 2012, 64:249-255.
37. Mlyniec K., Davies C.L., Budziszewska B., Opoka W., Reczynski W., Sowa-Kucma M., et al. Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol Rep 2012, 64:567-575.
38. Mlyniec K., Budziszewska B., Reczynski W., Sowa-Kucma M., Nowak G. The role of the GPR39 receptor in zinc deficient-animal model of depression. Behav Brain Res 2013, 238:30-35.
39. Młyniec K., Doboszewska U., Szewczyk B., Sowa-Kućma M., Misztak P., Piekoszewski W., et al. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims. Neuropharmacology 2014, 79:290-297.
40. Nibuya M., Takahashi M., Russell D.S., Duman R.S. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999, 267:81-84.
41. Nowak G., Siwek M., Dudek D., Zieba A., Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 2003, 55:1143-1147.
42. Nowak G., Szewczyk B., Wieronska J.M., Branski P., Palucha A., Pilc A., et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 2003, 61:159-164. [DOI: S0361923003001047].
43. Opoka W., Sowa-Kucma M., Stachowicz K., Ostachowicz B., Szlosarczyk M., Stypula A., et al. Early lifetime zinc supplementation protects zinc-deficient diet-induced alterations. Pharmacol Rep 2010, 62:1211-1217.
44. Palazidou E. The neurobiology of depression. Br Med Bull 2012, 101:127-145.
45. Paoletti P., Ascher P., Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 1997, 17:5711-5725.
46. Paoletti P., Vergnano A.M., Barbour B., Casado M. Zinc at glutamatergic synapses. Neuroscience 2009, 158:126-136.
47. Pilc A., Wieronska J.M., Skolnick P. Glutamate-based antidepressants: preclinical psychopharmacology. Biol Psychiatry 2013, 73:1125-1132.
48. Pochwat B., Szewczyk B., Sowa-Kucma M., Siwek A., Doboszewska U., Piekoszewski W., et al. Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharmacol 2014, 17:393-405.
49. Quan M.N., Zhang N., Wang Y.Y., Zhang T., Yang Z. Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model. Neuroscience 2011, 182:88-97.
50. Ranjbar E., Kasaei M.S., Mohammad-Shirazi M., Nasrollahzadeh J., Rashidkhani B., Shams J., et al. Effects of zinc supplementation in patients with major depression: a randomized clinical trial. Iran J Psychiatry 2013, 8:73-79.
51. Rosa A.O., Lin J., Calixto J.B., Santos A.R., Rodrigues A.L. Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 2003, 144:87-93. [DOI: S016643280300069X].
52. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965, 122:509-522.
53. Sheng M., Kim E. The postsynaptic organization of synapses. Cold Spring Harb Perspect Biol 2011, 3. 10.1101/cshperspect.a005678.
54. Siwek M., Dudek D., Paul I.A., Sowa-Kucma M., Zieba A., Popik P., et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 2009, 118:187-195. 10.1016/j.jad.2009.02.014.
55. Skolnick P. Antidepressants for the new millennium. Eur J Pharmacol 1999, 375:31-40.
56. Skolnick P., Popik P., Trullas R. Glutamate-based antidepressants: 20years on. Trends Pharmacol Sci 2009, 30:563-569.
57. Solati Z., Jazayeri S., Tehrani-Doost M., Mahmoodianfard S., Gohari M.R. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial. Nutr Neurosci 2014, 10.1179/1476830513Y.0000000105.
58. Sowa-Kucma M., Legutko B., Szewczyk B., Novak K., Znojek P., Poleszak E., et al. Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm 2008, 115:1621-1628. 10.1007/s00702-008-0115-7.
59. Sowa-Kucma M., Szewczyk B., Sadlik K., Piekoszewski W., Trela F., Opoka W., et al. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord 2013, 151:924-931.
60. Sterlemann V., Rammes G., Wolf M., Liebl C., Ganea K., Muller M.B., et al. Chronic social stress during adolescence induces cognitive impairment in aged mice. Hippocampus 2010, 20:540-549.
61. Swardfager W., Herrmann N., Mazereeuw G., Goldberger K., Harimoto T., Lanctot K.L. Zinc in depression: a meta-analysis. Biol Psychiatry 2013, 10.1016/j.biopsych.2013.05.008.
62. Szewczyk B., Poleszak E., Wlaz P., Wrobel A., Blicharska E., Cichy A., et al. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:323-329.
63. Szewczyk B., Poleszak E., Sowa-Kucma M., Wrobel A., Slotwinski S., Listos J., et al. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids 2010, 39:205-217. 10.1007/s00726-009-0412-y.
64. Szewczyk B., Kubera M., Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:693-701.
65. Tamano H., Kan F., Kawamura M., Oku N., Takeda A. Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation. Neurochem Int 2009, 55:536-541.
66. Tassabehji N.M., Corniola R.S., Alshingiti A., Levenson C.W. Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav 2008, 95:365-369.
67. Thomas C.G., Miller A.J., Westbrook G.L. Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J Neurophysiol 2006, 95:1727-1734.
68. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28-40.
69. Vashum K.P., McEvoy M., Milton A.H., McElduff P., Hure A., Byles J., et al. Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord 2014, 166:249-257.
70. Whittle N., Lubec G., Singewald N. Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 2009, 36:147-158.
71. WHO The global burden of disease: 2004 update 2008.
72. Williams K. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. Neurosci Lett 1996, 215:9-12.
73. Zarate C.A., Singh J.B., Quiroz J.A., De Jesus G., Denicoff K.K., Luckenbaugh D.A., et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry 2006, 163:153-155.